SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 188 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $23,319 | -41.7% | 13,249 | +4.0% | 0.00% | -60.0% |
| Q4 2022 | $39,985 | +471.2% | 12,734 | +848.9% | 0.01% | +400.0% |
| Q3 2022 | $7,000 | -56.2% | 1,342 | -65.5% | 0.00% | -50.0% |
| Q2 2022 | $16,000 | +1500.0% | 3,892 | +2287.7% | 0.00% | – |
| Q1 2022 | $1,000 | – | 163 | +83.1% | 0.00% | – |
| Q1 2020 | $0 | – | 89 | +50.8% | 0.00% | – |
| Q4 2019 | $0 | – | 59 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 59 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 59 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 59 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 59 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | – | 59 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 59 | -88.5% | 0.00% | -100.0% |
| Q1 2018 | $9,000 | +12.5% | 514 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $8,000 | +14.3% | 514 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $7,000 | +75.0% | 514 | 0.0% | 0.00% | +50.0% |
| Q2 2017 | $4,000 | +100.0% | 514 | 0.0% | 0.00% | +100.0% |
| Q1 2017 | $2,000 | – | 514 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,032,980 | $12,950,000 | 1.82% |
| EcoR1 Capital, LLC | 2,308,079 | $14,702,000 | 1.54% |
| Alexandria Capital, LLC | 1,005,119 | $6,403,000 | 1.05% |
| Casdin Capital, LLC | 1,455,000 | $9,268,000 | 0.98% |
| Rhenman & Partners Asset Management AB | 700,000 | $4,459,000 | 0.62% |
| Bellevue Group AG | 3,850,000 | $24,525,000 | 0.48% |
| GREAT POINT PARTNERS LLC | 633,505 | $4,035,000 | 0.42% |
| WASATCH ADVISORS LP | 5,938,434 | $37,828,000 | 0.39% |
| 361 CAPITAL LLC | 109,161 | $695,000 | 0.32% |
| Ceeto Capital Group, LLC | 50,000 | $319,000 | 0.26% |